Open Label Extension study of PTC505

• Research type

  Research Study

• Full title

  A PHASE 3 EXTENSION STUDY OF ATALUREN (PTC124) IN PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY

• IRAS ID

  152238

• Contact name

  Kate Bushby

• Contact email

  kate.bushby@ncl.ac.uk

• Sponsor organisation

  PTC Therapeutics, Inc.

• Eudract number

  2013-005489-20

• ISRCTN Number

  0

• Clinicaltrials.gov Identifier

  0

• REC name

  Wales REC 3

• REC reference

  14/WA/0189

• Date of REC Opinion

  22 Aug 2014

• REC opinion

  Further Information Favourable Opinion